icon
body
VYNDAMAX is used to treat adults with wild-type or hereditary ATTR-CM to reduce death and hospitalization related to heart problems.
name
link
dismiss
false
image
Actor portrayal of a grandfather gardening with his grandchild
mobile_image
Actor portrayal of a grandfather gardening with his grandchild
eyebrow
headline

Patient support and advocacy

content
buttons
disclaimer
headline

Transthyretin cardiac amyloidosis (ATTR-CM) support groups

content
These organizations can provide you with more information, connect you with support groups, and let you hear from other people with the condition*:
eyebrow
disclaimer
*These websites are neither owned nor controlled by Pfizer. Pfizer does not endorse and is not responsible for the content or services of these sites.
card_identifier
Logo from amyloidosis support groups where patients can get support from other ATTR-CM patients and caregivers
Mobile_image
Logo from amyloidosis support groups where patients can get support from other ATTR-CM patients and caregivers
Image_caption
heading
body
The Amyloidosis Support Groups provide information about ongoing ATTR-CM support and work to educate on and raise awareness of amyloidosis for all those affected by the disease.
cta
card_identifier
Logo from amyloidosis research consortium where patients can get support from other ATTR-CM patients and caregivers
Mobile_image
Logo from amyloidosis research consortium where patients can get support from other ATTR-CM patients and caregivers
Image_caption
heading
body
The  Amyloidosis Research Consortium  (ARC) offers comprehensive support and information for those living with amyloidosis throughout their journey. ARC aims to promote the development of and access to new and innovative treatments, and foster the research that will have the greatest impact on people living with the disease.
cta
card_identifier
Logo from amyloidosis foundation where patients can get support from other ATTR-CM patients and caregivers
Mobile_image
Logo from amyloidosis foundation where patients can get support from other ATTR-CM patients and caregivers
Image_caption
heading
body
The  Amyloidosis Foundation  works to drive research for an earlier diagnosis. The foundation also serves to educate medical professionals and assist patients through a broad range of services.
cta
icon
headline

If you’ve been diagnosed with hereditary ATTR-CM, your loved ones may also be at risk

content
It’s important for patients with hereditary ATTR-CM to tell their families about their condition. This allows family members to make a decision as to whether they want to pursue genetic testing and counseling.
disclaimer
buttons
Learn more
icon
headline

One-on-one disease education

content
A Pfizer Patient Navigator (PN) can provide patients and caregivers useful disease education if you are suspecting or diagnosed with ATTR-CM.
disclaimer
buttons
Sign up to speak to a PN
image
Vyndacares logo, a program that provides helpful information about ATTR-CM and VYNDAMAX (tafamidis). See safety info.
Mobile_image
Vyndacares logo, a program that provides helpful information about ATTR-CM and VYNDAMAX (tafamidis). See safety info.
eyebrow
headline

Get to the heart of what matters

subheadline
content
Stay informed with educational materials about ATTR-CM and VYNDAMAX.
buttons
Sign up
content2
disclaimer
Image_disclaimer
Brightcove_video_id
Brightcove_account_id
eyebrow
headline

Explore downloadable resources

headline2
content
content2
buttons
Learn more
Cta_brightcove_account_id
Cta_brightcove_video_id
disclaimer